Fig. 2.
Skewing of VB repertoire in AA, described in percent of skewing among 21 VB subfamilies (mean±SD).
(A) Healthy controls. (B) New AA. (C) Patients with AA with HLA-DR2. (D) Patients with AA with HLA-A2. (E) Patients with PNH/AA. *P < .05; ** P < .01.